Screening compound: InChI=1S/C15H13FN6O3/c16-10-2-1-3-11(8-10)22-9-12(18-20-22)13-17-14(25-19-13)15(23)21-4-6-24-7-5-21/h1-3,8-9H,4-7H2

Screening compound: InChI=1S/C15H13FN6O3/c16-10-2-1-3-11(8-10)22-9-12(18-20-22)13-17-14(25-19-13)15(23)21-4-6-24-7-5-21/h1-3,8-9H,4-7H2
Screening compound: InChI=1S/C15H13FN6O3/c16-10-2-1-3-11(8-10)22-9-12(18-20-22)13-17-14(25-19-13)15(23)21-4-6-24-7-5-21/h1-3,8-9H,4-7H2 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C15H13FN6O3/c16-10-2-1-3-11(8-10)22-9-12(18-20-22)13-17-14(25-19-13)15(23)21-4-6-24-7-5-21/h1-3,8-9H,4-7H2

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P508-0225

Molecular Formula

C15H13FN6O3 (C15 H13 FN6 O3)

Compound Name

4-{3-[1-(3-fluorophenyl)-1H-1,2,3-triazol-4-yl]-1,2,4-oxadiazole-5-carbonyl}morpholine

IUPAC name

4-{3-[1-(3-fluorophenyl)-1H-123-triazol-4-yl]-124-oxadiazole-5-carbonyl}morpholine

SMILES

O=C(c1nc(-c2cn(-c3cccc(F)c3)nn2)no1)N1CCOCC1

InChI

InChI=1S/C15H13FN6O3/c16-10-2-1-3-11(8-10)22-9-12(18-20-22)13-17-14(25-19-13)15(23)21-4-6-24-7-5-21/h1-3,8-9H,4-7H2

InChI Key

FJZFMYXVHPBWRO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27577574

InChI=1S/C15H13FN6O3/c16-10-2-1-3-11(8-10)22-9-12(18-20-22)13-17-14(25-19-13)15(23)21-4-6-24-7-5-21/h1-3,8-9H,4-7H2 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with InChI=1S/C15H13FN6O3/c16-10-2-1-3-11(8-10)22-9-12(18-20-22)13-17-14(25-19-13)15(23)21-4-6-24-7-5-21/h1-3,8-9H,4-7H2 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C15H13FN6O3/c16-10-2-1-3-11(8-10)22-9-12(18-20-22)13-17-14(25-19-13)15(23)21-4-6-24-7-5-21/h1-3,8-9H,4-7H2?
Check Price and Availability of InChI=1S/C15H13FN6O3/c16-10-2-1-3-11(8-10)22-9-12(18-20-22)13-17-14(25-19-13)15(23)21-4-6-24-7-5-21/h1-3,8-9H,4-7H2, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C15H13FN6O3/c16-10-2-1-3-11(8-10)22-9-12(18-20-22)13-17-14(25-19-13)15(23)21-4-6-24-7-5-21/h1-3,8-9H,4-7H2 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C15H13FN6O3/c16-10-2-1-3-11(8-10)22-9-12(18-20-22)13-17-14(25-19-13)15(23)21-4-6-24-7-5-21/h1-3,8-9H,4-7H2
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C15H13FN6O3/c16-10-2-1-3-11(8-10)22-9-12(18-20-22)13-17-14(25-19-13)15(23)21-4-6-24-7-5-21/h1-3,8-9H,4-7H2
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C15H13FN6O3/c16-10-2-1-3-11(8-10)22-9-12(18-20-22)13-17-14(25-19-13)15(23)21-4-6-24-7-5-21/h1-3,8-9H,4-7H2 available by request